Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antichemokine immunotherapy for allergic diseases.

A D Luster1

  • 1Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, massachusetts General Hospital, Harvard Medical School, Boston, USA. luster@helix.mgh.harvard.edu

Current Opinion in Allergy and Clinical Immunology
|April 20, 2002
PubMed
Summary

Chemokines regulate leukocyte function and are key targets for treating allergic diseases. Targeting specific chemokines and their receptors offers a promising new approach for allergy immunotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.

Nature communications·2015
Same author

Colonic patch and colonic SILT development are independent and differentially regulated events.

Mucosal immunology·2012
Same author

Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.

American journal of physiology. Lung cellular and molecular physiology·2011
Same author

Allergic asthma: a tale of many T cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2008
Same author

Variant eotaxin: its effects on the asthma phenotype.

The Journal of allergy and clinical immunology·2001
Same author

CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).

Journal of immunology (Baltimore, Md. : 1950)·2001

Area of Science:

  • Immunology
  • Allergy Research
  • Molecular Medicine

Background:

  • Chemokines are crucial regulators of leukocyte function.
  • They play significant roles in both innate and acquired immune responses.
  • Chemokines are increasingly recognized as therapeutic targets for allergic diseases.

Purpose of the Study:

  • To investigate the role of specific chemokines and their receptors in allergic inflammation.
  • To explore the potential of targeting these molecules for allergy immunotherapy.

Main Methods:

  • Analysis of chemokine and chemokine receptor expression in allergic inflammation.
  • Utilizing inhibitory antibodies and chemokine antagonists to block specific pathways.

Main Results:

Related Experiment Videos

  • A subset of chemokines (e.g., eotaxin-1, MCP-3, TARC) and their receptors (CCR3, CCR4, CCR8) are highly expressed in allergic inflammation.
  • These molecules are expressed on key leukocytes involved in allergic responses, including T helper type 2 cells and eosinophils.
  • Interfering with these chemokine pathways demonstrates potential therapeutic benefits.

Conclusions:

  • Specific chemokines and their receptors are critically involved in allergic inflammation.
  • Targeting this chemokine subset represents a novel and promising strategy for allergy immunotherapy.